Francis Shupo

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Cross Sectional

Clinical Evaluation

Patient Reported

Top Venues

Oncology and therapy

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Franklin, Francis Shupo, Grace Wayi-Wayi, Natasa Zibelnik, Emily Jones, Nicola Mason, John E Brazier, Sudipto Mukherjee
Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease. Oncology and therapy (2024)
Matthew Franklin, Francis Shupo, Grace Wayi-Wayi, Natasa Zibelnik, Emily Jones, Nicola Mason, John E Brazier, Sudipto Mukherjee
Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease. Oncology and therapy 12 (3) (2024)
Matthew Franklin, Francis Shupo, Grace Wayi-Wayi, Natasa Zibelnik, Emily Jones, Nicola Mason, John E Brazier, Sudipto Mukherjee
Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease. Oncology and therapy 12 (3) (2024)
Matthew Franklin, Francis Shupo, Grace Wayi-Wayi, Natasa Zibelnik, Emily Jones, Nicola Mason, John E Brazier, Sudipto Mukherjee
Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease. Oncology and therapy 12 (3) (2024)
Francis Shupo, Keith R Abrams, Zanfina Ademi, Grace Wayi-Wayi, Natasa Zibelnik, Matt Kirchmann, Carolyn Rutherford, Kelly Makarounas-Kirchmann
Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease. PharmacoEconomics - open (2023)